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Background: To inform health care and training, resource and research priorities, it is essential to establish how
non-communicable disease risk factors vary by HIV-status in high HIV burden areas; and whether long-term
anti-retroviral therapy (ART) plays a modifying role.
Methods: As part of a cohort initiation, we conducted a baseline HIV/cardiometabolic risk factor survey in
2010–2011 using an age-sex stratified random sample of ages 15+ in rural South Africa. We modelled cardiometabolic
risk factors and their associations by HIV-status and self-reported ART status for ages 18+ using sex-stratified logistic
regression models.
Results: Age-standardised HIV prevalence in women was 26% (95% CI 24-28%) and 19% (95% CI 17–21) in
men. People with untreated HIV were less likely to have a high waist circumference in both women (OR 0.67;
95% CI 0.52-0.86) and men (OR 0.42; 95% CI 0.22-0.82). Untreated women were more likely to have low HDL
and LDL, and treated women high triglycerides. Cardiometabolic risk factors increased with age except low
HDL. The prevalence of hypertension was high (40% in women; 30% in men).
Conclusions: Sub-Saharan Africa is facing intersecting epidemics of HIV and hypertension. In this setting, around half
the adult population require long-term care for at least one of HIV, hypertension or diabetes. Together with the adverse
effects that HIV and its treatment have on lipids, this may have serious implications for the South African health care
system. Monitoring of the interaction of HIV, ART use, and cardiometabolic disease is needed at both individual and
population levels.
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Reflecting a complex health transition, the population of
South Africa is ageing as widespread lifestyle changes
occur and antiretroviral therapy (ART) for HIV/AIDS
becomes more readily available. Thus a co-morbid bur-
den of cardiometabolic disease and HIV/AIDS is emer-
ging. The South African population carries a rising
prevalence of cardiometabolic diseases and their risk fac-
tors [1-6], including poor communities in rural South
African settings [7]. Mortality from cardiometabolic dis-
eases increased substantially in the first decade of this* Correspondence: brian.houle@anu.edu.au
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unless otherwise stated.century [8] with little change since, despite national ini-
tiatives to address the problem [9].
South Africa has the largest population living with
HIV/AIDS world-wide [9] and the largest ART programme,
with nearly 2 million people on treatment by 2011 [9].
The scale-up of antiretroviral therapy and declining mor-
tality due to improved survival of people living with HIV/
AIDS suggests an increased burden of cardiometabolic
diseases and associated risk factors [10]. The growing need
for chronic care of both HIV/AIDS and cardiometabolic
diseases, in South Africa and regionally, highlights the im-
portance of greater understanding of the burden of cardio-
metabolic diseases in this population [11].
In the present study, based on cross-sectional data
from rural South Africa, we aimed to examine the fac-
tors associated with higher cardiometabolic risk, andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Demographic and lifestyle variables by sex,
Agincourt sub-district, South Africa, 2010–2011 [All estimates
include sampling weights; percentages may not sum to
100 due to rounding]
Women (%)
(N = 2163)
Men (%)
(N = 1478)
Age (years)
18-29 38 64
30-49 31 15
50+ 31 21
Formal education, years
None 23 11
1-5 10 10
6+ 67 80
Ever smoked 1 21
Currently employed 14 15
Alcohol frequency, past 30 days
None 94 67
1 – 3 days/month 4 17
1 – 4 days/week 2 12
5+ days/week 1 4
Physical activity scorea
Low 47 38
Moderate 34 40
High 18 22
aBased on the International Physical Activity Questionnaire (IPAQ).
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with HIV-status.
Methods
Setting and participants
We conducted a cross-sectional HIV/cardiometabolic risk
factor survey in 2010 – 2011 using an age-sex stratified
random sample of those aged 15+ in the Agincourt sub-
district, situated in rural north-eastern South Africa adja-
cent to the country’s border with Mozambique. The
sub-district has been under health and demographic sur-
veillance since 1992, with collection of longitudinal data
on all vital events and possible social, economic and en-
vironmental modifiers [12,13]. It is one of South Africa’s
poorest areas, characterised by limited subsistence farm-
ing, shortage of services and high levels of migrant labor
coupled with limited local employment opportunities. The
area characteristics and the surveillance system are ex-
plained in more detail elsewhere [14].
For this cross-sectional study we randomly selected
7662 individuals ages 15+, stratified by age and sex, from
an eligible population of 34,413 using the 2009 census
update as the sampling frame [15]. In addition, we in-
cluded 284 adults over age 50 years who participated in
the INDEPTH-WHO/SAGE (http://www.who.int/healthinfo/
sage/en/) ageing and adult health study in 2006 [16]. Of
these individuals, 4362 consented to be interviewed and
tested; we restricted our estimation sample to ages 18+
with complete covariate data (n = 3641). We used an indi-
cator of household socioeconomic status [17] from the
2009 census update.
Ethical approval
The study received ethical approvals from the University
of the Witwatersrand Human Research Ethics Committee
and the Mpumalanga Provincial Research and Ethics
Committee. Written consent to participate (or parental
consent and assent for minors ages 15–17) was obtained
for all participants.
Availability of supporting data
Data extraction of the Agincourt HDSS can be requested
from Dr. F. Xavier Gómez-Olivé (F.Gomez-OliveCasas@
wits.ac.za). Complete data sharing and collaboration details
are available elsewhere [14].
Procedures
A questionnaire on cardiometabolic risk factors, medica-
tion use and sexual behaviour was administered by expe-
rienced local fieldworkers who visited households up to
three times to recruit the sample population. Five dried
blood spots provided measures of HIV-status (HIV-, un-
treated HIV+, and treated HIV+). Treatment status was
assessed by self-report. Point-of-care instruments wereused to measure glycaemia, total cholesterol and lipid
sub-fractions. Respondents were asked about smoking and
alcohol history, physical activity, dietary intake, time since
the last meal and whether they were using antiretroviral
therapy. Physical measurements included height, weight
and waist circumference using a flexible stadiometer (Seca,
Hamburg, Denmark); and Analysis Scale Body Check (Seca,
Hamburg, Denmark). Blood pressure was measured three
times with a Boso blood pressure instrument (BOSCH+
SOHN, Jungingen, Germany) three minutes apart, taken on
the left wrist with participant in sitting positions and at rest;
taking the average of the last two measurements. Random
blood glucose was measured with a Caresens POP blood
glucose meter (i-Sens, Nowon-gu, Seoul Korea); and total
cholesterol and lipid sub-fractions were measured using a
Cardiochek instrument (Polymer Technology Systems Inc.,
Indianapolis, IN USA). Socio-demographic characteristics
such as years of formal education and employment were
extracted from the existing surveillance system database.
Variables used
To evaluate the association between cardiometabolic risk
factors and HIV status, we determined different cut-offs
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and aimed, whenever possible, to select an internation-
ally recognized definition: high waist circumference as
greater than 102 cm for men and 88 cm for women [18];
hypertension as systolic blood pressure greater than or
equal to 140 mmHg or diastolic blood pressure greater
than or equal to 90 mmHg or current use of antihyper-
tensive medication [18]; high LDL cholesterol as greater
than 3 mmol/l [19]; low HDL cholesterol as less than
1.03 mmol/l for men and 1.29 mmol/l for women [18];
high triglycerides as greater than or equal to 1.7 mmol/l
[18]; high total cholesterol/ HDL ratio as greater than 8
[19]; diabetes as blood glucose (fasting or not; most of the
blood samples were non-fasting) greater than or equal to
11.1 mmol/L [19]; obesity as body mass index of (BMI;
kg/m2) 30 or higher [18]; and HIV-serostatus (HIV-, un-
treated HIV+, and treated HIV+). Personal and household
socio-demographic characteristics included sex, age,
formal education received (none, 1–5, 6+ years), smokingTable 2 Unadjusted and age-adjusted prevalence of HIV and ca
South Africa, 2010–2011 [All estimates include sampling weigh
population; figures are % (with 95% confidence intervals]
Women
Unadjusted Age-adjuste
HIV+ 23 26
[21, 24] [24, 28]
Hypertensiona (whole sample) 40 39
[38, 43] [37, 41]
Hypertensiona (HIV negative) 40 40
[38, 43] [37, 42]
High waist circumferenceb 42 43
[40, 45] [41, 45]
Probable diabetesc 3 2
[2, 4] [2, 3]
Obesityd 25 26
[23, 27] [24, 28]
High triglyceridese 23 22
[21, 25] [20, 23]
High LDL cholesterolf 31 28
[28, 33] [25, 30]
Low HDL cholesterolg 28 29
[26, 30] [27, 32]
Any condition requiring chronic careh 54 56
[52, 57] [53, 58]
aSystolic blood pressure greater than or equal to 140 mmHg, or diastolic blood pre
bGreater than 102 cm for men and 88 cm for women.
cRandom blood glucose greater than or equal to 11.1.
dBody mass index (kg/m2) 30 or higher.
eGreater than or equal to 1.7 mmol/l.
fGreater than or equal to 3.0 mmol/l.
gLess than 1.04 mmol/l for men and 1.29 mmol/l for women.
hEither HIV+, hypertensive or diabetic.history (ever smoked or not), physical activity (low, mod-
erate, high) [20], household asset score (in tertiles), em-
ployment status (currently employed or not), and alcohol
frequency in the past month (no use, 1–3 days/month,
1–4 days/week, or 5+ days/week).
Statistical methods
We calculated the unadjusted prevalence of HIV and
cardio-metabolic risk factors by sex; and age-adjusted
prevalence using the Agincourt 2009 census population.
We used logistic regression to assess associations be-
tween cardiometabolic risk factors and HIV-status and a
number of socio-demographic variables including sex,
age, formal education, smoking history, physical activity,
household asset score, employment status, and alcohol
intake in the past month. We first fitted baseline models
including HIV-status and covariates assumed to be un-
affected by HIV-status (education and smoking history).
We then estimated the full model with all covariates tordiometabolic risk factors by sex, Agincourt sub-district,
ts; age adjustment based on 2009 Agincourt census
Men
d Unadjusted Age-adjusted p-value (age-adjusted)
10 19 <0.001
[9, 11] [17, 21]
30 37 0.301
[27, 33] [35, 40]
29 37 0.233
[26, 32] [35, 41]
4 6 <0.001
[3, 5] [5, 8]
1 2 0.328
[1, 2] [1, 3]
5 7 <0.001
[3, 6] [5, 8]
20 24 0.096
[17, 22] [22, 27]
14 17 <0.001
[11, 16] [15, 20]
16 12 <0.001
[14, 19] [10, 14]
36 49 <0.001
[33, 40] [46, 51]
ssure greater than or equal to 90 mmHg or use of antihypertensive medication.
Table 3 Influence of HIV serostatus, treatment status, and personal and household attributes on cardiometabolic risk
among women in Agincourt sub-district 2010–2011 [All estimates include sampling weights]
Odds ratio [95% CI]
Obesityc High waist
circumferenced
Diabetese Hypertensionf High triglyceridesg High LDL
cholesterolh
Low HDL
cholesteroli
HIV status
HIV- − − − −
HIV+, no treatment 0.64 0.67 0.4 0.82 1.19 0.53 1.38
[0.49, 0.85] [0.52, 0.86] [0.15, 1.04] [0.63, 1.07] [0.90, 1.57] [0.38, 0.73] [1.06, 1.81]
HIV+, on treatment 0.27 0.5 0.64 0.74 1.65 0.83 0.56
[0.15, 0.46] [0.33, 0.76] [0.18, 2.23] [0.49, 1.10] [1.10, 2.48] [0.51, 1.33] [0.33, 0.95]
Age groups
18-29 0.27 0.21 0.22 0.29 0.51 0.58 2.08
[0.20, 0.37] [0.16, 0.28] [0.07, 0.76] [0.22, 0.39] [0.37, 0.71] [0.40, 0.83] [1.60, 2.72]
30-49 − − − −
50+ 1.03 1.73 4.53 2.39 1.57 2.79 0.55
[0.78, 1.35] [1.33, 2.24] [2.37, 8.64] [1.83, 3.10] [1.18, 2.08] [2.09, 3.72] [0.40, 0.76]
SES tertilesa
1st (lowest) − − − −
2nd 1.65 1.46 1.36 1.1 1.3 1.04 0.9
[1.26, 2.15] [1.15, 1.87] [0.71, 2.61] [0.86, 1.42] [0.98, 1.71] [0.77, 1.40] [0.68, 1.19]
3rd (highest) 1.92 1.84 1.72 1.03 1.35 1.09 0.84
[1.47, 2.52] [1.43, 2.37] [0.94, 3.16] [0.79, 1.33] [1.02, 1.79] [0.81, 1.48] [0.62, 1.13]
Currently employed 1.28 1.41 1 1.21 1.12 0.84 0.89
[0.99, 1.67] [1.08, 1.84] [0.46, 2.17] [0.93, 1.57] [0.84, 1.49] [0.61, 1.15] [0.66, 1.20]
Ever smoked 0.41 0.5 1.18 2.2 1.33 0.76 1.25
[0.16, 1.09] [0.23, 1.06] [0.25, 5.43] [0.86, 5.60] [0.59, 3.01] [0.34, 1.70] [0.46, 3.41]
Physical activityb
Low − − − −
Moderate 0.93 1.04 1.22 0.72 1.06 0.77 0.96
[0.74, 1.17] [0.83, 1.31] [0.70, 2.14] [0.57, 0.90] [0.83, 1.36] [0.59, 1.01] [0.74, 1.24]
High 0.85 0.88 0.94 0.71 0.91 0.77 0.84
[0.62, 1.17] [0.66, 1.17] [0.43, 2.06] [0.53, 0.96] [0.65, 1.27] [0.54, 1.10] [0.60, 1.18]
Alcohol frequency, past month
Not in past 30 days − − − −
1 – 3 days/month 0.54 1.14 Omitted 1.08 1.32 0.6 0.77
[0.27, 1.09] [0.64, 2.05] [0.63, 1.88] [0.68, 2.56] [0.28, 1.26] [0.38, 1.58]
1 – 4 days/week 0.89 1.11 0.69 0.54 1.6 0.49 0.65
[0.38, 2.05] [0.56, 2.19] [0.15, 3.17] [0.29, 0.97] [0.69, 3.71] [0.22, 1.06] [0.22, 1.97]
5+ days/week 0.14 0.72 Omitted 0.75 1.91 1.05 0.36
[0.02, 1.05] [0.23, 2.24] [0.24, 2.32] [0.35, 10.32] [0.27, 4.06] [0.03, 3.88]
Formal education
None − − − −
1 – 5 years 1.45 1.3 0.9 0.74 0.87 1.17 1.18
[1.04, 2.01] [0.94, 1.80] [0.43, 1.91] [0.53, 1.03] [0.61, 1.23] [0.82, 1.67] [0.77, 1.79]
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Table 3 Influence of HIV serostatus, treatment status, and personal and household attributes on cardiometabolic risk
among women in Agincourt sub-district 2010–2011 [All estimates include sampling weights] (Continued)
6+ years 1.45 1.38 1.46 0.88 0.93 0.93 1.36
[1.08, 1.95] [1.04, 1.84] [0.78, 2.71] [0.66, 1.17] [0.68, 1.25] [0.68, 1.27] [0.97, 1.92]
N 2057 2064 1984 2064 2064 1601 2064
aBased on an household asset index score in 2009.
bBased on the International Physical Activity Questionnaire (IPAQ).
cBody mass index (kg/m2) 30 or higher.
dGreater than 88 cm.
eBlood glucose greater than or equal to 11.1.
fSystolic blood pressure greater than or equal to 140 mmHg, or diastolic blood pressure greater than or equal to 90 mmHg or use of antihypertensive medication.
gGreater than or equal to 1.7 mmol/l.
hGreater than or equal to 3.0 mmol/l.
iLess than 1.29 mmol/l.
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HIV-status with each outcome. The HIV-status coeffi-
cients were not substantively changed by including all
covariates so we present the full estimation results. All
analyses were completed using STATA 12.1 and in-
cluded sampling weights [21].
Results
Demographic and lifestyle variables are presented in
Table 1. Nearly two-thirds of the study sample were women,
reflecting the demographic effect of widespread male-
oriented migrant labour patterns in the study setting. Very
few women reported ever smoking or drinking alcohol in
the past month.
Age-adjusted adult HIV prevalence was 26% for women
(95% CI 24–28) and 19% for men (95% CI 17–21) (Table 2).
Overall measures of body shape and composition (waist
circumference and BMI) showed markedly higher levels of
abdominal and general obesity in women. There was no
difference in the age-adjusted prevalence of hypertension
by sex. Prevalence of hypertension was similar for the
whole population (including HIV + and HIV -), and for
those HIV negative only.
Median values of cardiometabolic risk factors by sex,
age-group and HIV and ART treatment status are shown
in (Additional file 1: Table S1). Prevalence of cardiomet-
abolic risk factors by sex, age-group, HIV and ART treat-
ment status are shown in (Additional file 1: Figure S1).
Results of the logistic regression are shown in Tables 3
and 4. We excluded the total cholesterol/HDL ratio from
the logistic regression since there were only eight indi-
viduals with a value greater than 8.
For women, after adjusting for age, education, house-
hold SES and employment status, as well as smoking
status, physical activity, and alcohol use, untreated HIV+
status was associated with lower odds of obesity (OR
0.64; 95% CI 0.49-0.85), high waist circumference (OR
0.67; 95% CI 0.52-0.86), and high LDL (OR 0.53; 95%
CI 0.38-0.73) relative to HIV- female respondents; and
higher odds of low HDL (OR 1.38; 95% CI 1.06-1.81)
(Table 3). Treated HIV+ women were at lower odds ofobesity (OR 0.27; 95% CI 0.15-0.46), high waist circumfer-
ence (OR 0.50; 95% CI 0.33-0.76), and low HDL (OR 0.56;
95% CI 0.33-0.95) relative to HIV- women. There was
an increased odds of high triglycerides (OR 1.65; 95%
CI 1.10-2.48) among treated women compared with HIV-
women.
The odds of elevated risk markers in women increased
with age for all cardiometabolic risk factors except low
HDL cholesterol (in which the odds decreased with age).
Living in a higher SES household relative to the lowest
SES households (first quintile) increased the odds of
obesity, high waist circumference and high triglycerides.
Current employment was associated with a higher waist
circumference; and having any formal education increased
the odds of obesity. Being physically active was associated
with decreased odds of hypertension.
For men, after adjusting for age, education, household
SES and employment status, as well as smoking status,
physical activity and alcohol use, untreated HIV+ status
was associated with reduced odds of high waist circum-
ference (OR 0.42; 95% CI 0.22-0.82) and raised LDL
cholesterol (OR 0.42; 95% CI 0.25-0.72) relative to HIV-
male respondents (Table 4). Age associations with cardio-
metabolic risk factors were comparable to those of women
but the association was only statistically significant for
hypertension, high LDL cholesterol and low HDL choles-
terol. Being in the highest SES household relative to the
lowest increased the odds of high waist circumference and
raised triglycerides. Risk of hypertension increased with
increasing SES, although the odds ratio for hypertension
in the highest level of SES relative to the lowest did not
quite reach statistical significance. Current employment
increased the odds of hypertension and high triglycerides.
Trends with alcohol consumption were inconsistent.
Discussion
We have described the prevalence of HIV and cardio-
metabolic risk factors in a rural South African popula-
tion 18 years and older. We found a high prevalence of
HIV and cardiovascular risk factors, particularly hyper-
tension, in this population.
Table 4 Influence of HIV serostatus, treatment status, and personal and household attributes on cardiometabolic risk
among men in Agincourt sub-district 2010–2011 [All estimates include sampling weights]
Odds ratio [95% CI]
Obesityc High waist
circumferenced
Diabetese Hypertensionf High triglyceridesg High LDL
cholesterolh
Low HDL
cholesteroli
HIV status
HIV- − − − −
HIV+, no treatment 0.78 0.42 1.13 0.76 0.81 0.42 1.15
[0.44, 1.40] [0.22, 0.82] [0.46, 2.75] [0.52, 1.11] [0.55, 1.18] [0.25, 0.72] [0.66, 2.01]
HIV+, on treatment Omittedj Omittedj 1 1.23 1.4 0.57 0.45
[0.20, 5.11] [0.70, 2.17] [0.79, 2.50] [0.27, 1.18] [0.13, 1.56]
Age groups
18-29 0.22 0.15 Omittedj 0.48 0.37 0.31 1.74
[0.10, 0.50] [0.06, 0.39] [0.33, 0.68] [0.25, 0.54] [0.18, 0.53] [1.07, 2.83]
30-49 − − − −
50+ 0.96 1.59 4.15 2.59 1.21 2.04 0.3
[0.49, 1.90] [0.88, 2.86] [1.82, 9.50] [1.79, 3.76] [0.80, 1.83] [1.27, 3.29] [0.13, 0.71]
SES tertilesa
1st (lowest) − − − −
2nd 1.06 1.31 1.34 1.57 1.06 0.86 1.22
[0.43, 2.61] [0.59, 2.90] [0.51, 3.51] [1.06, 2.33] [0.69, 1.63] [0.50, 1.47] [0.70, 2.11]
3rd (highest) 2.13 2.98 2.29 1.44 1.83 0.78 1.02
[0.97, 4.68] [1.48, 6.00] [0.93, 5.62] [0.98, 2.11] [1.20, 2.79] [0.46, 1.32] [0.57, 1.82]
Currently employed 1.34 1.18 0.84 1.47 1.72 1.14 0.8
[0.87, 2.07] [0.75, 1.87] [0.41, 1.73] [1.04, 2.09] [1.21, 2.43] [0.76, 1.70] [0.48, 1.32]
Ever smoked 0.7 0.88 1.28 0.84 0.76 0.97 1.12
[0.29, 1.66] [0.39, 2.00] [0.59, 2.80] [0.60, 1.17] [0.55, 1.06] [0.58, 1.63] [0.63, 1.99]
Physical activityb
Low − − − −
Moderate 1.91 1.59 0.85 0.84 1.01 0.76 1.06
[1.12, 3.28] [0.94, 2.69] [0.40, 1.82] [0.59, 1.18] [0.69, 1.48] [0.49, 1.18] [0.64, 1.75]
High 0.42 0.45 2.8 1.02 1.6 0.61 0.89
[0.17, 1.02] [0.12, 1.63] [0.94, 8.36] [0.62, 1.67] [0.93, 2.74] [0.26, 1.44] [0.46, 1.71]
Alcohol frequency, past month
Not in past 30 days − − − −
1 – 3 days/month 0.8 0.99 0.54 1.97 1.07 0.44 0.99
[0.33, 1.95] [0.41, 2.40] [0.19, 1.57] [1.29, 3.00] [0.67, 1.71] [0.26, 0.75] [0.57, 1.72]
1 – 4 days/week 0.49 0.38 0.6 1.18 2.21 1.31 0.26
[0.22, 1.09] [0.16, 0.92] [0.18, 1.96] [0.77, 1.83] [1.37, 3.55] [0.66, 2.57] [0.10, 0.65]
5+ days/week 0.84 0.42 0.22 1.05 1.13 0.16 0.16
[0.24, 2.95] [0.15, 1.20] [0.03, 1.97] [0.61, 1.81] [0.61, 2.08] [0.06, 0.44] [0.02, 1.22]
Formal education
None − − − −
1 – 5 years 2.31 1.66 0.62 0.81 1.04 1.34 0.47
[0.91, 5.87] [0.85, 3.24] [0.22, 1.70] [0.51, 1.29] [0.60, 1.80] [0.77, 2.33] [0.16, 1.38]
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Table 4 Influence of HIV serostatus, treatment status, and personal and household attributes on cardiometabolic risk
among men in Agincourt sub-district 2010–2011 [All estimates include sampling weights] (Continued)
6+ years 1.37 1.54 1.47 0.76 1.29 1.48 0.37
[0.60, 3.11] [0.80, 2.98] [0.65, 3.35] [0.49, 1.17] [0.79, 2.11] [0.82, 2.65] [0.13, 1.01]
N 1293 1300 940 1369 1369 1031 1369
aBased on an household asset index score in 2009.
bBased on the International Physical Activity Questionnaire (IPAQ).
cBody mass index (kg/m2) 30 or higher.
dGreater than 102 cm.
eBlood glucose greater than or equal to 11.1.
fSystolic blood pressure greater than or equal to 140 mmHg, or diastolic blood pressure greater than or equal to 90 mmHg or use of antihypertensive medication.
gGreater than or equal to 1.7 mmol/l.
hGreater than or equal to 3.0 mmol/l.
iLess than 1.04 mmol/l.
jCategory omitted due to small sample size.
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from a well-established health and demographic surveil-
lance system with clear field and data entry procedures
to ensure the quality of information [14,22]. We were
thus able to include socio-demographic variables for par-
ticipants and could calculate age-standardised preva-
lence estimates.
We assessed ART use by self-report which was likely
underestimated since there remains considerable stigma
associated with HIV [23,24]. Moreover, we acknowledge
that some forms of ART used by our respondents may
affect their lipid levels and insulin resistance [25,26], and
we cannot isolate this possible effect. We were not able
to measure fasting glucose because of the distances be-
tween households and road conditions, which meant
that early morning visits to participants were not practical.
Also resulting from logistical considerations, metabolic
risk factors were measured using point of care instru-
ments instead of laboratory analysis. We used internation-
ally recognized cut-offs for all cardiometabolic risk factors
but it is possible that using different cut-offs results may
have varied.
The WHO-SAGE study of older people conducted in
2006 and covering six countries in Asia, Africa and Latin
America found that South Africa had the highest recorded
levels of hypertension (78%) [27]. This was higher than
findings from a similar study in the Agincourt sub-district
where the prevalence of hypertension in the popula-
tion 50 years and above was 57% [16]. In the present
study, which includes all age groups from 18 years, the
age-standardised prevalence was 39% in women and 37%
in men. It is clear that South Africa is facing an epidemic
of hypertension.
A recent systematic review considered the association
of HIV and ART with cardiometabolic risk factors in
sub-Saharan Africa [28]. Using data from 52 studies,
which reported on nearly 30,000 individuals, the review
found that untreated HIV was associated with lower
BMI and HDL and raised triglycerides. These findings
were confirmed in this study for women. The review alsoreported lower systolic and diastolic blood pressure in
people with HIV but we did not find any significantly
different risk in recorded hypertension. Our results and
the results of the review highlight the importance of
establishing the relationship between HIV status, use of
ART and cardiometabolic diseases. In the region with the
largest number of people infected with HIV and an in-
creasing number of people suffering from cardiovascular
diseases, establishing the association between them is an
urgent priority.
The findings on cardiovascular risk factors in people tak-
ing ART could not be established in our study as we were
limited to self-reported ART use. Our finding of lower
BMI in those on ART may be explained by the fact that
when data were collected, national policy was that ART
should be initiated only when the CD4 count was below
200 cells/mm3 [29] – meaning that these people were
already very sick when treatment was initiated.
Conclusions
Sub-Saharan Africa is facing parallel and interacting epi-
demics of HIV and cardiometabolic disease risk that are
fuelled by complex health and social transitions. Our
results indicate both a high prevalence of HIV and of
hypertension in a poor, rural South African population.
Although we did not find any interaction between these
two conditions, it is inevitable that some people will be af-
fected by both and our results show that around half of
the adult population (56% of women and 49% of men,
Table 2) are in need of long-term care for at least one of
HIV, hypertension or diabetes. This carries serious implica-
tions for the South African health system and strengthens
our prior argument, based on comprehensive cause-
of-death trends, that delivery of functionally integrated
chronic care will be critical to meeting health needs at the
primary care level [7].
We have also confirmed the results of an earlier sys-
tematic review, that the presence of HIV has an adverse
effect on HDL cholesterol and triglycerides, suggesting
that people living with HIV may be at increased risk
Clark et al. BMC Public Health  (2015) 15:135 Page 8 of 9of cardiovascular disease, and that there may be an accel-
eration of the already increasing prevalence of cardiometa-
bolic conditions. As yet, we have only measured self-reported
ART status. However, in the context of continued ART
rollout, an ageing population, and increasing HIV preva-
lence in the older population, future monitoring of ART
access and use, and the interaction with cardiometabolic
risk factors is urgently needed to understand and quantify
the challenges both to the health service and the wider
society.
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